- Home
- REVG vs BSX Comparison
REVG vs BSX Comparison
Compare REVG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVG
- BSX
- Stock Information
- Founded
- REVG 2008
- BSX 1979
- Country
- REVG United States
- BSX United States
- Employees
- REVG N/A
- BSX N/A
- Industry
- REVG Auto Manufacturing
- BSX Medical/Dental Instruments
- Sector
- REVG Consumer Discretionary
- BSX Health Care
- Exchange
- REVG Nasdaq
- BSX Nasdaq
- Market Cap
- REVG 2.2B
- BSX 138.4B
- IPO Year
- REVG 2017
- BSX 1992
- Fundamental
- Price
- REVG $50.25
- BSX $104.32
- Analyst Decision
- REVG Hold
- BSX Strong Buy
- Analyst Count
- REVG 4
- BSX 22
- Target Price
- REVG $41.25
- BSX $112.86
- AVG Volume (30 Days)
- REVG 779.9K
- BSX 8.0M
- Earning Date
- REVG 06-04-2025
- BSX 07-23-2025
- Dividend Yield
- REVG 0.48%
- BSX N/A
- EPS Growth
- REVG N/A
- BSX 15.23
- EPS
- REVG 1.86
- BSX 1.37
- Revenue
- REVG $2,331,500,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- REVG $3.60
- BSX $17.50
- Revenue Next Year
- REVG $6.89
- BSX $10.75
- P/E Ratio
- REVG $26.98
- BSX $76.12
- Revenue Growth
- REVG N/A
- BSX 19.36
- 52 Week Low
- REVG $21.54
- BSX $71.88
- 52 Week High
- REVG $50.29
- BSX $107.53
- Technical
- Relative Strength Index (RSI)
- REVG 81.57
- BSX 54.04
- Support Level
- REVG $43.12
- BSX $102.67
- Resistance Level
- REVG $45.16
- BSX $107.53
- Average True Range (ATR)
- REVG 1.15
- BSX 1.82
- MACD
- REVG 0.29
- BSX 0.28
- Stochastic Oscillator
- REVG 99.44
- BSX 66.32
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.